MPC vs MPLT · P/E 16, rev $138.86B vs $1.24B cap
Marathon Petroleum Corp (MPC) versus MapLight Therapeutics, Inc. Common Stock (MPLT) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
MPLT does not have a complete income-statement cache yet.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. MPLT currently screens at market cap $1.24B.
Not investment advice. Open the MPC and MPLT stock pages for the full models.
Not investment advice.